Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases von de Boer, M., Adang, E.M.M., Van Dycke, K.C.G., van Dijck, J.A.A.M., Borm, G.F., Seferina, S.C., van Deurzen, C.H.M., van Diest, P.J., Bult, P., Donders, A.R.T., Tjan-Heijnen, V.C.G.

Volltext